ID28088A - Antibodi untuk cd23, turunan-turunannya dan penggunannya untuk terapi - Google Patents

Antibodi untuk cd23, turunan-turunannya dan penggunannya untuk terapi

Info

Publication number
ID28088A
ID28088A IDW20002573A ID20002573A ID28088A ID 28088 A ID28088 A ID 28088A ID W20002573 A IDW20002573 A ID W20002573A ID 20002573 A ID20002573 A ID 20002573A ID 28088 A ID28088 A ID 28088A
Authority
ID
Indonesia
Prior art keywords
declaration
antibody
therapy
Prior art date
Application number
IDW20002573A
Other languages
English (en)
Inventor
Jean-Yves Marcel Paul Bonnefoy
Scott James Crowe
Jonathan Henry Ellis
Nicholas Timothy Rapson
Jean Shearin
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ID28088A publication Critical patent/ID28088A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IDW20002573A 1998-05-09 1999-05-07 Antibodi untuk cd23, turunan-turunannya dan penggunannya untuk terapi ID28088A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9809839.5A GB9809839D0 (en) 1998-05-09 1998-05-09 Antibody

Publications (1)

Publication Number Publication Date
ID28088A true ID28088A (id) 2001-05-03

Family

ID=10831668

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002573A ID28088A (id) 1998-05-09 1999-05-07 Antibodi untuk cd23, turunan-turunannya dan penggunannya untuk terapi

Country Status (25)

Country Link
US (1) US7008623B1 (id)
EP (1) EP1076701A1 (id)
JP (1) JP2002514421A (id)
KR (1) KR20010043470A (id)
CN (1) CN1308676A (id)
AP (1) AP1547A (id)
AU (1) AU763491B2 (id)
BR (1) BR9910327A (id)
CA (1) CA2328606A1 (id)
EA (1) EA200001041A1 (id)
EE (1) EE200000658A (id)
GB (1) GB9809839D0 (id)
HR (1) HRP20000762A2 (id)
HU (1) HUP0102005A3 (id)
ID (1) ID28088A (id)
IL (1) IL139384A0 (id)
IS (1) IS5696A (id)
NO (1) NO20005632L (id)
NZ (1) NZ507879A (id)
PL (1) PL344019A1 (id)
SK (1) SK16762000A3 (id)
TR (1) TR200003281T2 (id)
WO (1) WO1999058679A1 (id)
YU (1) YU69000A (id)
ZA (1) ZA200006312B (id)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696550B2 (en) 1998-07-23 2004-02-24 Millennium Pharmaceuticals, Inc. Humanized anti-CCR2 antibodies and methods of use therefor
WO2002030986A2 (en) 2000-10-13 2002-04-18 Biogen, Inc. HUMANIZED ANTI-LT-β-R ANTIBODIES
US20040151721A1 (en) 2001-10-19 2004-08-05 O'keefe Theresa Humanized anti-CCR2 antibodies and methods of use therefor
AU2003248782A1 (en) * 2002-07-01 2004-01-19 Biogen Idec Ma Inc. Humanized anti-lymphotoxin beta receptor antibodies
TWI323265B (en) 2002-08-06 2010-04-11 Glaxo Group Ltd Antibodies
GB0306309D0 (en) 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
JP5068072B2 (ja) 2003-06-27 2012-11-07 バイオジェン・アイデック・エムエイ・インコーポレイテッド 連結ペプチドを含む改変された結合分子
CA2434668A1 (en) 2003-07-04 2005-01-04 Laurence Mulard Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a
EP2135619A1 (en) * 2003-12-10 2009-12-23 Millennium Pharmaceuticals, Inc. Humanized anti-CCR2 antibodies and methods of use therefor
US7435799B2 (en) * 2004-01-08 2008-10-14 Applied Molecular Evolution TNF-α binding molecules
CN1980957A (zh) 2004-03-23 2007-06-13 比奥根艾迪克Ma公司 受体偶联剂及其治疗用途
US20060246075A1 (en) * 2004-09-29 2006-11-02 Marc Mercken Anti-amyloid antibodies, compositions, methods and uses
WO2006074399A2 (en) 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Multispecific binding molecules comprising connecting peptides
BRPI0618705B8 (pt) * 2005-11-14 2021-05-25 Labrys Biologics Inc anticorpos antagonistas humanizados direcionados contra peptídeo relacionado ao gene da calcitonina, composição farmacêutica e uso dos mesmos
GB0525662D0 (en) 2005-12-16 2006-01-25 Glaxo Group Ltd Immunoglobulins
EP1804172B1 (en) * 2005-12-20 2021-08-11 Roche Diagnostics GmbH PCR elbow determination using curvature analysis of a double sigmoid
US7680868B2 (en) * 2005-12-20 2010-03-16 Roche Molecular Systems, Inc. PCR elbow determination by use of a double sigmoid function curve fit with the Levenburg-Marquardt algorithm and normalization
WO2009043051A2 (en) * 2007-09-27 2009-04-02 Biogen Idec Ma Inc. Cd23 binding molecules and methods of use thereof
CN104650235A (zh) 2007-11-30 2015-05-27 葛兰素集团有限公司 抗原结合构建体
CA2716424C (en) 2008-03-04 2015-04-28 Pfizer Limited Methods of treating chronic pain
CL2009001076A1 (es) 2008-05-06 2010-09-24 Glaxo Group Ltd Nanoparticulas que comprende una sustancia formadora de particulas y una proteina; composicion que comprende dichas nanoparticulas; procedimiento para suministrar una proteina a traves de la membrana hematoencefalica; uso de la composicion para profilaxis o tratar enfermedades del sistema nervioso central.
WO2010097385A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Antigen-binding constructs
WO2010097386A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Antigen-binding constructs
JP2012518400A (ja) 2009-02-24 2012-08-16 グラクソ グループ リミテッド 多価および/または複数特異的rankl結合性構築物
WO2010115786A1 (en) 2009-04-01 2010-10-14 Glaxo Group Limited Anti-il-23 immunoglobulins
US20120058116A1 (en) 2009-04-24 2012-03-08 Andrew Beaton Fgfr1c antibody combinations
RU2535074C2 (ru) 2009-08-28 2014-12-10 Лэйбрис Байолоджикс, Инк. Способы лечения висцеральной боли путем введения антител-антагонистов, направленных против пептида, связанного с геном кальцитонина
FR2957598B1 (fr) 2010-03-17 2015-12-04 Lfb Biotechnologies Nouveau peptide signal, et son utilisation pour la production de proteines recombinantes
UY33743A (es) 2010-11-23 2012-06-29 Glaxo Group Ltd Proteínas de unión a antígenos
JP2014501725A (ja) 2010-11-24 2014-01-23 グラクソ グループ リミテッド Hgfを標的とする多特異的抗原結合タンパク質
US8974782B2 (en) 2011-02-07 2015-03-10 Glaxo Group Limited Treatment of stroke comprising anti-MAG antibodies
PT3415531T (pt) 2011-05-27 2023-09-12 Glaxo Group Ltd Proteínas de ligação a bcma (cd269/tnfrsf17
EP2888279A1 (en) 2012-08-22 2015-07-01 Glaxo Group Limited Anti lrp6 antibodies
US10176293B2 (en) 2012-10-02 2019-01-08 Roche Molecular Systems, Inc. Universal method to determine real-time PCR cycle threshold values
CA2902831C (en) 2013-03-15 2023-04-25 Glaxosmithkline Intellectual Property Development Limited Anti-lag-3 binding proteins
JP6440036B2 (ja) * 2013-07-10 2018-12-19 オンコノックス エーピーエス 抗β2−グリコプロテインI抗体及びその治療的用法
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
RS65360B1 (sr) 2014-03-21 2024-04-30 Teva Pharmaceuticals Int Gmbh Antagonistička antitela specifična za peptid genski srodan kalcitoninu i postupci njihove upotrebe
WO2017037203A1 (en) 2015-09-02 2017-03-09 Immutep S.A.S. Anti-LAG-3 Antibodies
US10479827B2 (en) 2016-05-31 2019-11-19 Sysmex Corporation Monoclonal antibody reacting with glycopeptide, and use thereof
JP6935184B2 (ja) * 2016-05-31 2021-09-15 シスメックス株式会社 糖ペプチドと反応するモノクローナル抗体およびその用途
WO2017220990A1 (en) 2016-06-20 2017-12-28 Kymab Limited Anti-pd-l1 antibodies
MX2019003337A (es) 2016-09-23 2019-09-26 Teva Pharmaceuticals Int Gmbh Tratamiento para migraña refractaria.
KR20220026585A (ko) 2019-06-26 2022-03-04 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 Il1rap 결합 단백질
CN112552403A (zh) * 2020-12-25 2021-03-26 南京英瀚斯生物科技有限公司 一种人源抗人CD23抗体的Fab片段、药物组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU673499B2 (en) 1991-07-25 1996-11-14 Biogen Idec Inc. Recombinant antibodies for human therapy
IE922437A1 (en) * 1991-07-25 1993-01-27 Idec Pharma Corp Recombinant antibodies for human therapy
EP0788514A1 (en) * 1994-10-25 1997-08-13 Glaxo Group Limited Binding agents for treatment of inflammatory, autoimmune or allergic diseases
US6011138A (en) * 1997-02-20 2000-01-04 Idec Pharmaceuticals Corporation Gamma-1 anti-human CD23 monoclonal antibodies

Also Published As

Publication number Publication date
IS5696A (is) 2000-10-31
HUP0102005A3 (en) 2003-10-28
BR9910327A (pt) 2001-01-30
JP2002514421A (ja) 2002-05-21
AP2000001983A0 (en) 2000-12-31
PL344019A1 (en) 2001-09-24
NO20005632D0 (no) 2000-11-08
EA200001041A1 (ru) 2001-06-25
US7008623B1 (en) 2006-03-07
KR20010043470A (ko) 2001-05-25
NO20005632L (no) 2001-01-08
SK16762000A3 (sk) 2001-07-10
CN1308676A (zh) 2001-08-15
AU3836799A (en) 1999-11-29
EE200000658A (et) 2002-04-15
IL139384A0 (en) 2001-11-25
TR200003281T2 (tr) 2001-03-21
GB9809839D0 (en) 1998-07-08
WO1999058679A1 (en) 1999-11-18
HUP0102005A2 (hu) 2001-10-28
HRP20000762A2 (en) 2001-06-30
CA2328606A1 (en) 1999-11-18
NZ507879A (en) 2004-02-27
ZA200006312B (en) 2003-02-26
YU69000A (sh) 2003-08-29
AP1547A (en) 2006-01-13
AU763491B2 (en) 2003-07-24
EP1076701A1 (en) 2001-02-21

Similar Documents

Publication Publication Date Title
ID28088A (id) Antibodi untuk cd23, turunan-turunannya dan penggunannya untuk terapi
DE69825451D1 (de) Kanüle mit mehreren leitungen
DE69803087D1 (de) Integrierte einzelchip dualmode raidsteuerung
ID19824A (id) Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya
DE69809393D1 (de) Gasabsorption
DE69935516D1 (de) Antikörper mit verbesserter produzierbarkeit
ID28990A (id) Herbisida-herbisida dengan urea aminofenilsulfonil asilasi
ID16966A (id) Sediaan antibodi pekat
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
ID22957A (id) Senyawa dan penggunaannya
DE69833286D1 (de) Inhalationsgerät
IS5487A (is) Innúðatæki
ID24490A (id) Metode untuk menggunakan dan metode pembuatan tabung oven-pijar
ID26599A (id) Turunan triazola dan imidazola
ID29052A (id) Turunan-turunan 3,3-biarilpiperidina dan 2,2-biarilmorfolina
DE69941535D1 (de) Katalytische verbrennungseinrichtung
ID23258A (id) Penarik pemberian-menyilang dan metodenya
FR2763507B1 (fr) Inhalateur
DE69810858D1 (de) Einlassgeräuschdämpfer
ID24633A (id) Turunan tetrahidropirimidinon 3-tersubstitusi, pembuatan dan penggunaannya
DE69817679D1 (de) Teilchenfilter
DE69824327D1 (de) Inhalationsgerät
DE69840029D1 (de) Katalytischer verbrennungsheizer
ID28905A (id) Antibodi-antibodi dengan afinitas tinggi
ATE233048T1 (de) Dosiervorrichtung